Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension

por Safdar, Zeenat
Publicado 2011

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease

por Jyothula, Soma, Safdar, Zeenat
Publicado 2009

Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol

por Abughazaleh, Shaadi, Safdar, Zeenat
Publicado 2020

Chronic Thromboembolic Pulmonary Hypertension Medical Management

por Logue, Ryan, Safdar, Zeenat
Publicado 2021

Effect of spironolactone use in pulmonary arterial hypertension – analysis from pivotal trial databases

por Safdar, Zeenat, Cho, Eunah
Publicado 2021

Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension

por Oriaku, Ifeoma, Patel, Amol, Safdar, Zeenat
Publicado 2020

Use of Extracorporeal Membrane Oxygenation in Postpartum Management of a Patient with Pulmonary Arterial Hypertension

por Abid Memon, Humna, Safdar, Zeenat, Goodarzi, Ahmad
Publicado 2018

Spironolactone in pulmonary arterial hypertension: results of a cross-over study

por Safdar, Zeenat, Frost, Adaani, Basant, Arya, Deswal, Anita, O’Brian Smith, E., Entman, Mark
Publicado 2020

Longitudinal change in pulmonary arterial capacitance as an indicator of prognosis and response to therapy and in pulmonary arterial hypertension

por Medrek, Sarah K., Kloefkorn, Chad, Nguyen, Duc T.M., Graviss, Edward A., Frost, Adaani E., Safdar, Zeenat
Publicado 2017

Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting

por Balasubramanian, Vijay P., Safdar, Zeenat, Sketch, Margaret R., Broderick, Meredith, Nelsen, Andrew C., Lee, Dasom, Melendres‐Groves, Lana
Publicado 2022

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

por Vizza, Carmine Dario, Sastry, B. K. S., Safdar, Zeenat, Harnisch, Lutz, Gao, Xiang, Zhang, Min, Lamba, Manisha, Jing, Zhi-Cheng
Publicado 2017

Risk stratification and medical therapy of pulmonary arterial hypertension

por Galiè, Nazzareno, Channick, Richard N., Frantz, Robert P., Grünig, Ekkehard, Jing, Zhi Cheng, Moiseeva, Olga, Preston, Ioana R., Pulido, Tomas, Safdar, Zeenat, Tamura, Yuichi, McLaughlin, Vallerie V.
Publicado 2019

Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation

por Rahaghi, Franck F., Feldman, Jeremy P., Allen, Roblee P., Tapson, Victor, Safdar, Zeenat, Balasubramanian, Vijay P., Shapiro, Shelley, Mathier, Michael A., Elwing, Jean M., Chakinala, Murali M., White, R. James
Publicado 2017

A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Pr...

por Lee, Joshua D., Burger, Charles D., Delossantos, Genecelle B., Grinnan, Daniel, Ralph, David D., Rayner, Sam G., Ryan, John J., Safdar, Zeenat, Ventetuolo, Corey E., Zamanian, Roham T., Leary, Peter J.
Publicado 2020

Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Del...

por Rahaghi, Franck F., Safdar, Zeenat, Brown, Anne Whitney, de Andrade, Joao A., Flaherty, Kevin R., Kaner, Robert J., King, Christopher S., Padilla, Maria L., Noth, Imre, Scholand, Mary Beth, Shifren, Adrian, Nathan, Steven D.
Publicado 2020

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

por Bourge, Robert C, Tapson, Victor F, Safdar, Zeenat, Benza, Raymond L, Channick, Richard N, Rosenzweig, Erika B, Shapiro, Shelley, White, Richard James, McSwain, Christopher Shane, Gotzkowsky, Stephen Karl, Nelsen, Andrew C, Rubin, Lewis J
Publicado 2013

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study

por Rahaghi, Franck F., Kolaitis, Nicholas A., Adegunsoye, Ayodeji, de Andrade, Joao A., Flaherty, Kevin R., Lancaster, Lisa H., Lee, Joyce S., Levine, Deborah J., Preston, Ioana R., Safdar, Zeenat, Saggar, Rajan, Sahay, Sandeep, Scholand, Mary Beth, Shlobin, Oksana A., Zisman, David A., Nathan, Steven D.
Publicado 2022

Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression

por Ruan, Peifeng, Todd, Jamie L, Zhao, Hongyu, Liu, Yi, Vinisko, Richard, Soellner, Julia F., Schmid, Ramona, Kaner, Robert J., Luckhardt, Tracy R., Neely, Megan L., Noth, Imre, Porteous, Mary, Raj, Rishi, Safdar, Zeenat, Strek, Mary E, Hesslinger, Christian, Palmer, Scott M., Leonard, Thomas B., Salisbury, Margaret L.
Publicado 2023

Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat

por Rahaghi, Franck F., Balasubramanian, Vijay P., Bourge, Robert C., Burger, Charles D., Chakinala, Murali M., Eggert, Michael S., Elwing, Jean M., Feldman, Jeremy, King, Christopher, Klinger, James R., Mathai, Stephen C., McConnell, John Wesley, Palevsky, Harold I., Restrepo‐Jaramillo, Ricardo, Safdar, Zeenat, Sager, Jeffrey S., Sood, Namita, Sulica, Roxana, White, R. James, Hill, Nicholas S.
Publicado 2022